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Symposium

Epidemiology of pediatric urolithiasis
Ajay P. Sharma, Guido Filler
Division of Nephrology, Department of Pediatrics, University of Western Ontario, Children’s Hospital, London Health
Sciences Center, London, Ontario, Canada

ABSTRACT
Pediatric urolithiasis has increased globally in the last few decades. There has been a change in the pattern of stone
composition with an increase in the frequency of kidney stones and a decrease in bladder stones. The role of familial
predisposition and environmental factors in pediatric urolithiasis is now better understood. Metabolic factors are more
common in pediatric urolithiasis than in adult stone disease. This review updates on the epidemiology of pediatric
urolithiasis with a focus on the changing trends in the stone disease, current spectrum of stone disease encountered in
clinical practice, individual predisposition and the role of environmental factors in stone formation.
Key words: Epidemiology, pediatric, prevalence, trends, urolithiasis

INTRODUCTION
Pediatric urolithiasis is an important kidney disorder
encountered in clinical practice. There has been
considerable regional variability in the reported
incidences of urolithiasis. Also, there is a growing
body of evidence demonstrating that the overall
incidence of pediatric urolithiasis is increasing. A
better understanding of different risk factors can help
with risk stratification in an individual subject and can
guide specific measures to prevent stone recurrence.
This review focuses on the current state of knowledge
on the prevalence of pediatric urolithiasis, temporal
trends in stone disease and the status of different
risk factors in stone formation. The risk factors for
urolithiasis include an individual’s susceptibility
to form stones, such as genetic predisposition and
metabolic abnormalities, and environmental factors
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that facilitate stone disease, such as dietary practices as well
as local climate characteristics.

PREVALENCE OF UROLITHIASIS
Prevalence of urolithiasis varies in different countries.
In adults, the prevalence is relatively higher in Western
countries than in the Eastern hemisphere. The reported
prevalence of urolithiasis increases from 1-5% in Asia,
to 5-9% in Europe, 12% in Canada and 13- 15% in the
USA, although even some Asian countries, such as Saudi
Arabia, have a very high reported prevalence of 20.1%. [1,2]
Children represent 2-3% of the total population of stoneformers. [3] Similar to the regional variability seen in adults,
the prevalence of pediatric urolithiasis also varies in different
parts of the world. In the USA, urolithiasis is said to be
responsible for 1 in 7,600 to 1 in 1,000 pediatric hospital
admissions.[4] In asymptomatic Turkish primary school
children the prevalence of pediatric urolithiasis is reported to
be 1%.[5] Urolithiasis contributed to 7% of general outpatient
consultations in all children’s hospitals in Venezuela during
1998.[6] In a hospital-based study from Ethiopia, 13% of
admissions were due to urolithiaisis, and close to half of
these admissions were in the age group of 0-19 years.[7] The
prevalence might be higher than what hospital-based studies
suggest, as subjects with asymptomatic stones may be missed.
This point was highlighted by a 3.5% prevalence of X-rayidentified calcifications in the upper urinary tract in a crosssectional study on 3398 randomly selected asymptomatic
Scottish adults.[8]
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factorial and may depend on local conditions and practices.
In a nationwide survey from USA on 1,167,009 adults, the
odds of stones among participants residing in Southeast USA
were nearly double of those living in the Northwest states.[9]
The risk of kidney stones in the USA increases from the West
to East and from the North to South.[9] The region of the
United States with a higher prevalence of kidney stones has
been labeled the “stone belt” [also called the “kidney stone
belt"]. The term “stone belt” dates back to at least 1976, and
it applies to the region in the Southeast USA that includes
Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi,
North Carolina, South Carolina, Tennessee, Virginia and
Kentucky [Figure 1]. Similar regional variation was observed
in an Italian study with a higher stone incidence in Southern
Italy compared to the North of Italy.[10] The Afro-Asian stone
belt stretches from Sudan, the Arab Republic of Egypt, Saudi
Arabia, the United Arab Emirates, the Islamic Republic of
Iran, Pakistan, India, Myanmar, Thailand, Indonesia to
Philippines. Within a stone belt, the incidence of urolithiasis
varies within the regions due to the local conditions and
practices.

TRENDS IN THE PREVALENCE AND PATTERN OF
UROLITHIASIS
The epidemiologic studies have shown a progressive increase
in the incidence of pediatric urolithiasis over the last few
decades, referred to as a "stone wave". An earlier study
from 1951 did not find a single case of urolithiasis in 21,835
children at the Babies Hospital in New York.[11] In later
studies from the 1960s and 1970s, urolithiasis in children
increased steadily.[12-14] These studies reported the incidence
of pediatric urolithiasis in the range of 1 in 6000, 1 in 7600
and 1 in 1850 hospitalized children.[12-14] This increase in
stone incidence has become more pronounced in recent
years. VanDervoort et al., reported a fivefold increase in
the prevalence of pediatric urolithiasis in North American
children in the last decade.[4] Similar trends were also
observed in other countries. Annual pediatric referrals for
urolithiasis in Turkey showed a fivefold increase in the last

decade.[15] It cannot be ruled out that advances in imaging
techniques contributed to the reported increase; however,
the trend has also paralleled with improved socioeconomic
conditions and increased consumption of a protein-rich
diet.[16,17]
Pediatric urolithiasis has also shown a change in the
pattern of stone composition and localization. At the
beginning of the last century, bladder calculi, composed
of ammonium urate were common in Europe; whereas
over the past 100 years the pattern has changed to a
higher frequency of calculi localized in the upper urinary
tract. Moreover, calcium oxalate and calcium phosphate
calculi became much more prevalent. [18] This change
has been reported from both developed and developing
countries. [15,19,20] Struvite stones have decreased in frequency
and their occurrence has become limited to children with
predisposed conditions such as obstructive uropathy and
recurrent urinary tract infections. Bladder stones composed
of ammonium urate and calcium still remain prevalent in
malnourished children[7,18,21-23] and are more commonly
reported in developing countries. Nonetheless, the pattern
of pediatric urolithiasis in developing countries is now
changing, which is similar to trend that was observed in
the Western hemisphere over the last century.[18]

STONE COMPOSITION
Calcium oxalate is the most common stone worldwide, and
accounts for 60-90% of pediatric urolithiasis.[4,15,17,19,20,24-28]
Sturvite constitutes 1-18% of the stones in developed
countries.[15,29] calcium phosphate accounts for 10-20%
stones.[30] Uric acid constitutes 5-10%, cystine 1-5% [1
in 15000 live births] and mixed or miscellaneous 4% of
the pediatric stones.[30,31] Cystine stones have a higher
prevalence in endemic areas and in communities with
high consanguinity. The reported prevalence of uncommon
stone types could be an underestimation in many developing
countries due to the unavailability of required diagnostic
tools.[32]

METABOLIC RISK FACTORS
Pediatric urolithiasis requires a comprehensive metabolic
evaluation to identify underlying risk factors. Metabolic
risk factors increase the risk of stone recurrence. [31,33]
The prevalence of metabolic risk factors ranged from less
than 20% to greater than 50% in different studies. [15,17,33,34]
Hypercalciuria and hypocitraturia are the common
metabolic abnormalities, detected in one-third of the
stone-formers. [4,15,34] The prevalence of hyperuricosuria
and hyperoxaluria has been reported to be approximately
20%.[15,29]

Hypercalciuria
Figure 1: Stone belt in North America
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in excess of 0.1 mmol/kg per 24 h or 4 mg/kg per 24 h.[35]
Hypercalciuria can be associated with elevated plasma
calcium levels, as in primary hyperparathyroidism, or it can
occur with normal serum calcium levels. Hypercalcemiaassociated hypercalciuria needs further evaluation of the
etiology of hypercalcemia. Normocalcemic hypercalciuria
can be an isolated trait, referred to as idiopathic
hypercalciuria, or it can have an associated abnormality such
as renal tubular acidosis. The term idiopathic hypercalciuria
was introduced by Albright and colleagues[36] to describe
normocalcemic hypercalciuria without an obvious etiology.
The defect in idiopathic hypercalciuria can be impaired
renal tubular calcium reabsorption [renal hypercalciuria]
or enhanced intestinal calcium absorption [absorptive
hypercalciuria]. An overlap of the two mechanisms can also
occur, although a differentiation does not change clinical
management or prognosis. Calcium balance is negative in
almost half the patients with idiopathic hypercalciuria,
which can be associated with a reduced bone mineral
density.[37,38] The pathogenesis of decreased bone mineral
density in this condition is thought to be secondary to a
combination of genetic factors, low calcium intake and
altered cytokine production.[39] Idiopathic hypercalciuria is
treated with a low-salt and high-fluid diet, potassium citrate
supplementation and thiazide diuretics.

Hypocitraturia

Urinary citrate inhibits the crystal precipitation and raises
the threshold for stone formation through the formation
of chelate complexes with calcium. Hypocitraturia can
be idiopathic or can be a manifestation of systemic
metabolic acidosis, hypokalemia[40,41] or inflammatory bowel
disease. Hypocitraturia is treated with potassium citrate
supplementation.

Hyperoxaluria

Urinary oxalate is mainly derived from endogenous
production of ascorbic acid and glyoxylate metabolism.
In normal circumstances, only 10-15% of urinary oxalate
originates from dietary intake. Food products with high
oxalate content include coffee, tea, vegetables such as beans,
canned tomatoes, cocoa and chocolate. The proportion
of dietary oxalate increases in gastrointestinal conditions
associated with fat malabsorption, inflammatory bowel
disease or bowel resection. These conditions aggravate
oxalate absorption either due to increased gut permeability
or by decreased calcium availability for oxalate binding.
Oxalate-rich or pyridoxine-deficient foods can also induce
enteric hyperoxaluria. Hyperoxaluria due to an inborn
error of metabolism is labeled as primary hyperoxaluria
[oxalosis]. Two types of hyperoxaluria are differentiated:
Type I and Type II. Type I hyperoxaluria is the more
common of the two and it occurs in 1 per 120,000 live
births. It is transmitted as an autosomal recessive trait. The
genetic mutation leads to the defect in enzyme alanine
glyoxylate aminotransferase [AGXT]. This enzyme defect
518

leads to an increase in urinary oxalate, glyoxylic acid and
glycolic acid. Type II hyperoxaluria is due to a defect in the
D-glycerate dehydrogenase enzyme, and it is associated with
an increase in urinary oxalate and L-glycerate levels. Lowoxalate, high-fluid and high-calcium diet, trial of pyridoxine
supplementation and potassium citrate administration in the
presence of low urinary citrate levels forms the cornerstone
of therapy. Severe cases can require combined liver-kidney
transplantation. It is important to note that a low-calcium
diet can cause secondary hyperoxaluria.

Urinary tract infection

Urinary tract infection from urease-producing organisms can
predispose to infection stones by splitting urea to ammonia
and CO2. Ammonia preconditions to the formation of struvite
and carbonate apatite stones in the presence of concomitant
alkaline urine.[21] The association of pediatric urolithiasis with
urinary tract infections is approximately 25%.[32] In pediatric
urolithiasis, the prevalence of genitourinary anatomical
abnormalities such as ureteropelvic junction obstruction
and vesicoureteric reflux can range at 14- 30%. [17,31]

FAMILIAL AND INHERITED PREDISPOSITION
First-degree relatives of stone-formers have a 2-16 times
higher risk of developing renal stones when compared with
the general population.[42,43] In a stone-former, the probability
of having a relative with stones may be as high as 35-65% as
compared with a 5-20% probability in a non-stone-former.
[43]
It is important to understand that familial recurrence does
not necessarily imply an inherited genetic cause. Shared
environmental factors and common dietary habits can
contribute to familial predisposition. After controlling for
dietary pattern, genetic factors have also been recognized
to play a significant role in urolithiasis.[44] The mode of
inheritance for the genetic factors is largely considered to be
polygenic.[45] Monogenic inheritance has been identified for
relatively less common etiologies such as cystinuria, primary
hyperoxaluria, and for selected etiologies of hypercalciuria
such as Dent’s disease [the association of low molecular
weight proteinuria and hypercalciuria], Bartter syndrome
Type V, autosomal dominant hypocalcemic hypercalciuria,
familial hypomagnesemia with hypercalciuria and
hypercalciuric nephrolithiasis with hypophosphatemia.[46]
Idiopathic hypercalciuria can have a familial predisposition
or can occur in a sporadic form. Family history could
be positive in up to 65% of patients with hypercalciuric
nephrolithiaisis. [47] In familial forms, the pattern of
transmission is found to be consistent with autosomal
dominant inheritance. [48] Familial pattern has been
reported for both absorptive hypercalciuria[48] and renal
hypercalciuria.[49] In pedigree analyses, genetic defect was
mapped to Chromosome 1q23.3–23.4[50] for human soluble
adenylate cyclase gene;[51] Chromosome 12q12-q14 for
vitamin D receptor [VDR] gene;[52] and to Chromosome
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9q33.2-q34.2, from which an appropriate candidate gene
remains to be identified.[53]

ETHNICITY AND GENDER

to be through different mechanisms. It results from a
combination of a higher renal load of lithogenic substances,
and a tendency towards their increased precipitation in
the kidneys. Animal proteins are rich in sulfur-containing
amino acids such as cystine and methionine. Oxidation of
sulfur to sulfate generates acid load that aggravates calcium
mobilization from bones.[59] High purine content in animal
protein increases the uric acid burden. Urine oxalate level
also increases with high protein intake.[60] High protein
load increases glomerular filtration and facilitates a higher
delivery of these substances to the urinary tract. Calcium
forms soluble complex with sulfate generated from the
oxidation of sulfur in proteins. Acid load increases calcium
mobilization from the bones, and causes hypercalciuria and
low urine citrate levels.[61]

Idiopathic stone disease has been reported to be more
frequent in white Caucasians than in African-Americans
from both adult and pediatric studies.[55] These differences
are difficult to explain based simply on ethnicity. Decrease in
ethnic disparity in the stone prevalence with the change in
dietary pattern in African-Americans suggests a predominant
role of environmental factors in the observed discrepancy.

Dietary sodium increases the risk of urolithiasis. Salt intake
expands intravascular volume, which can increase urinary
calcium level, likely by decreasing renal tubular calcium
reabsorption.[62] Increase in salt intake can induce mild
systemic metabolic acidosis, which can lower urinary citrate
levels, and increases the risk of calcium precipitation in
kidneys.[62]

With regard to gender distribution, males were found to be
more susceptible for stones in some pediatric studies,[19] an
observation not seen in other studies.[31]

On the contrary, potassium-rich foods lower stone formation
through a decrease in urinary calcium excretion. [63]
High urinary potassium is believed to increase renal
tubular phosphate absorption and consequently inhibit
1, 25-dihydroxyvitamin synthesis. [64] Decrease in 1,
25-dihydroxy vitamin slows intestinal calcium absorption.
Potassium-rich foods offer the additional advantage of high
citrate content thus decreasing the precipitation of urinary
calcium.[26]

The role of genetic factors in oxalate handling has been
the focus of a few studies. Recurrent idiopathic stoneformers have been reported to have a higher prevalence
of anomalous erythrocyte transmembrane oxalate flux. In
the affected families, the transmission pattern suggested an
autosomal monogenetic trait, with complete penetration
and a variable expressivity.[54] Hydrochlorothiazide and
amiloride have been shown to restore the oxalate flux to
normal.[54] The significance of oxalate flux in the clinical
management of nephrolithiasis needs further evaluation.

DIETARY HABITS
Epidemiologic studies indicate a major role of diet in the
pathogenesis of urolithiasis.
Both malnutrition and obesity increase the risk of
urolithiasis.[10] The increase in the stone disease with
malnutrition is associated with ammonium-urate stones
in the bladder, whereas obesity predisposes to calciumcontaining stones localized in the upper urinary tract. In
obesity, insulin resistance has been associated with an
increase in urinary calcium and decrease in renal tubular
acid excretion.[56] Impaired renal tubular acid excretion
lowers urinary citrate level and enhances the risk of stone
precipitation.
Evidence supports a link between higher dietary animal
protein and increase in stone incidence. [57] Protein
consumption in children in Europe and North America is
three to five times higher than the recommended intake.[58]
The increase in dietary protein has been associated with an
increase in calcium oxalate stones and higher localization
of stones in the kidneys.[10,16,17] Diet low in animal protein
but high in cereal shifts the spectrum towards a higher
predominance of bladder stones composed of ammonium
and urate ions, more commonly seen with malnutrition.[19,22]
The lithogenic potential of dietary protein is believed
Indian Journal of Urology, Oct-Dec 2010, Vol 26, Issue 4

Considering the key role of calcium in the pathogenesis of
urolithiasis, the interaction between dietary calcium and
the risk of urolithiasis has been controversial. High calcium
concentration in calcium oxalate and calcium phosphate
stones makes it sound intuitive that high dietary calcium
will increase urinary calcium levels and the risk of calcium
stones. On the other hand, a low-calcium diet can increase
intestinal oxalate absorption and enhance the risk of calcium
oxalate stones. This important question was addressed in a
prospective study on 45,619 men, aged 40 to 75 years, with
no history of kidney stones.[65] The risk of urolithiasis was
found to be inversely related to dietary calcium intake.[65]
With this evidence, dietary calcium restriction is no longer
recommended. The implication of dietary calcium becomes
even more significant in children, due to the importance of
adequate calcium intake for growth and bone metabolism
in the pediatric age group.
A carbohydrate-rich diet has been associated with an
increase in urolithiasis in predisposed subjects. Glucose load
can induce hypercalciuria, which is ascribed to decreased
distal tubular calcium absorption and augmented intestinal
519
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calcium uptake.[66] High glucose can also increase the risk of
urolithiasis through an increase in urinary oxalate levels.[67]

Climate and season

Parry and Lister were the first to propose that exposure to
sunlight might influence stone formation after they observed
an increase in urinary calcium among soldiers during
summer but not in winter months.[36] In a large voluntary
reported survey on 1,185,124 adults aged 30 years or older,
ambient temperature and sunlight exposure was positively
associated with stone prevalence after adjusting for other
relevant variables.[9] Incidence of urinary stones tends to
be higher in countries with warm or hot climates. Even
within North America, the prevalence of stones becomes
higher with an increase in average annual temperature
[5.2°C in North Dakota to 22°C in Florida] and sunlight
index [14.6 in Washington state to 39.7 in Florida].[9] In
a similar observation from Italy, the highest frequency of
urolithiasis was found in Southern Italy and the lowest in
Northern Italy.[10] Corresponding to high temperatures,
stone recurrence becomes higher in summer and fall than in
winter and spring.[17] The peak incidence of stone formation
occurs in July, August, and September[9,25-33] in the Northern
hemisphere.
The relationship between urolithiasis and high ambient
temperature can be explained by intravascular volume
contraction resulting from a combination of dehydration
and inadequate fluid intake. Volume contraction increases
urine concentration and promotes stone formation.[34,35]
Higher sunlight exposure can also increase the production
of 25-hydroxycholecalciferol in the skin, leading to an
increase in 1, 25 dihydroxyvitamin D levels which augments
intestinal calcium absorption. Elevated levels of circulating
1, 25 dihydroxyvitamin D have been found in patients with
hypercalciuria.[37]

LOCAL FACTORS AFFECTING STONE FORMATION
Local factors have been reported to affect the regional
distribution of pediatric urolithiasis.

Intestinal colonization of Oxalobacter formigenes [O.
formigenes]

Deficient intestinal colonization of Oxalobacter formigenes
[O. formigenes] in the North Indian population has been
associated with a higher frequency of urolithiasis in the local
population[68] O. formigenes is a Gram-negative, anaerobic
bacterium that metabolizes oxalate in the intestinal tract
and has a prevalence of 46-77% in different populations.[69]
Deficient intestinal colonization of O. formigenes has been
associated with increased risk of absorptive hyperoxaluria
and calcium oxalate stones.[68]
The reasons for lower colonization of O. formigenes
in certain populations are not well understood. Recent
520

antibiotic administration and local practices of antibiotic
use can affect O. formigenes colonization.[70] A study in
Ukrainian children provided early insight into the natural
history of O. formigenes.[69] O. formigenes was not detected
in children younger than one year, had a prevalence of
100% [by polymerase chain reaction ; approximately 80%
by culture] between ages six and eight, and dropped to
approximately 75% at age 12.[69] Long-term pattern of
O. formigenes colonization, loss and reacquisition of the
bacterium over the course needs evaluation.
The use of O. formigenes as a probiotic is at an early stage
of investigation. A preliminary trial on 16 patients showed
a reduction in urinary or plasma oxalate in 11 patients with
no adverse effects; however, none of the patients seemed to
be permanently colonized during follow-up.[71]

Endemic prevalence of distal renal tubular acidosis

Higher prevalence of renal stones in Northeast Thailand has
been attributed to the local endemicity of distal renal tubular
acidosis [RTA].[66] Distal RTA induces systemic metabolic
acidosis and increases the risk of urolithiasis by inducing
hypercalciuria and hypocitraturia. Even in the absence of
overt metabolic acidosis, intermittent and mild acidosis from
incomplete distal RTA is capable of causing hypercalciuria
and renal calculi.[61,72] In the presence of metabolic acidosis,
hypercalciuria results from calcium mobilization from
bones during acid buffering. Renal tubular acidification
defects can also lower urinary citrate levels. Low urinary
citrate concentration facilitates calcium precipitation in the
kidneys. Correction of acidosis offers a therapeutic benefit
in both complete and incomplete distal RTA.[73]

Exogenous substances

Melamine contamination in milk has been recently
associated with nephrolithiasis in infants. After initial
reports of nephrolithiasis among Chinese infants, attributed
to milk-based formula surfaced in the summer of 2008, a
systematic search by the Chinese Administration of Quality
Supervision, Inspection, and Quarantine [AQSIQ] revealed
22 commercial brands of milk powder with detectable levels
of melamine. [74] Melamine [1,3,5-triazine–2,4,6-triamine,
or C3H6N6], a synthetic chemical developed in the 1830s, is
used in a variety of inedible commercial products including
cleaning supplies, dry erase boards, and other plastics and
has widespread legitimate uses.[29] Melamine can increase
non-protein nitrogen content and manufacturers added it to
milk to meet quality control tests for protein-based nitrogen
content.
The mechanism of melamine nephrotoxicity is not completely
understood, although animal studies have provided some
insight. Melamine can precipitate in distal renal tubules and
forms intratubular green radial crystals which are distinct
from calcium oxalate or calcium phosphate crystals. [75]
Renal injury is believed to be secondary to an increase in
Indian Journal of Urology, Oct-Dec 2010, Vol 26, Issue 4
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intrarenal pressure resulting from crystal deposition in distal
tubule leading to intratubular obstruction and distal tubular
necrosis. Melamine stones are composed of melamine and
its metabolite cyanuric acid with uric acid, protein and
phosphate.[74] These stones are not fully radiopaque.

CONCLUSION
The incidence of urolithiasis in children has increased
globally over the last few decades. The pattern of stone
disease has also changed, with an increase in kidney stones
secondary to calcium oxalate or calcium phosphate in the
kidneys and a decrease in bladder stones composed of
ammonium and urate. Evidence favors a significant role of
dietary practices in the increase in pediatric urolithiasis.
There are marked regional variations in the stone prevalence
that has led to the recognition of ‘stone belts’. Local climatic
conditions play an important role in the stone pathogenesis.
Stone occurrence increases in warmer and sunnier regions.
The individual risk of stone disease is modified by familial
predisposition and genetic susceptibility. Metabolic workup
is indicated in all children with a stone disease. Adequate
water intake and maintaining a balanced diet are important
to reduce the risk of kidney stones. At-risk subjects identified
by metabolic workup can benefit by an intervention directed
to the specific defect.
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